Profile: STAAR Surgical Co (STAA.OQ)
25 May 2017
STAAR Surgical Company (STAAR), incorporated on April 3, 1986, designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. The Company's principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. The Company makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. The Company operates under the brands STAAR, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX nanoPOINT, Epiphany and AquaFlow. As of December 30, 2016, STAAR sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world. In Japan and Europe, it sells a Preloaded Injector with a silicone or acrylic IOL packaged and shipped in a pre-sterilized, disposable injector for use in cataract surgery. In China, it sells a Preloaded Injector with a silicone IOL packaged and shipped in a pre-sterilized disposable injector for use in cataract surgery.
STAAR operates its manufacturing facility in Monrovia, California. The Monrovia manufacturing facility principally makes Collamer and silicone intraocular lenses (IOLs), and injector systems for its IOLs. It also manufactures the Visian implantable Collamer lenses (ICLs) and preloaded IOL injectors. STAAR manufactures the raw material for Collamer lenses (both IOLs and ICLs) and the AquaFlow Device (for the treatment of glaucoma) in a facility in Aliso Viejo, California. STAAR operates a distribution facility in Nidau, Switzerland under its subsidiary, STAAR Surgical AG. The Nidau facility also maintains manufacturing capabilities for STAAR's ICL products and the AquaFlow Device. STAAR operates distribution facilities in Japan under its subsidiary, STAAR Japan Inc. STAAR Japan's facility is located in Shin-Urayasu and its distribution facility is located in Ichikawa City. STAAR final packages its silicone preloaded IOL injectors at the Ichikawa City facility.
The Company's refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). The field of refractive surgery includes both lens-based procedures, using products, such as ICL and laser-based procedures, such as LASIK. The ICL product line treats a range of refractive errors within commonly known vision disorders, such as myopia (nearsightedness), hyperopia (farsightedness) and astigmatism. The ICL folds for minimally invasive implantation behind the iris and in front of the natural crystalline lens, using techniques similar to those used to implant an IOL during cataract surgery, except that the natural lens remains intact in the eye. Lenses of this type are generically called phakic IOLs or phakic implants because they work along with the patient's natural lens, or phakos, rather than replacing it. The Company's ICL is available for myopia and hyperopia and is available in multiple models, powers and lengths totaling hundreds of different types of inventoried lenses.
The Company produces and markets a line of foldable IOLs for use in minimally invasive cataract surgical procedures. Because these lenses fold, surgeons can implant them into the eye through an incision of three millimeter (mm) in length. STAAR offers both materials in two differently configured styles: the single-piece design where both the optic and haptics are made of the same material and the three-piece design where Polyimide loop haptics are attached to the optic. STAAR also sells aspheric IOLs made of silicone and Collamer that use optical designs that produce a clearer image than traditional spherical lenses.
The Company also sells injector parts to its acrylic lens supplier for their preloaded acrylic IOL that they sell under their own brand. Also, the Company sells other related instruments and devices that it manufacture, or that are manufactured by others.
The Company competes with Novartis, Abbott Medical Optics, Valeant and Ophtec.
STAAR Surgical Co
1911 Walker Ave
MONROVIA CA 91016
Company Web Links
- BRIEF-Staar Surgical files for potential mixed shelf offering
- BRIEF-STAAR Surgical announces CE Mark approval for the EVO+ visian ICL with aspheric (EDOF) optic
- BRIEF-Staar Surgical reports Q1 sales $20.4 million
- BRIEF-Staar Surgical names Deborah Andrews interim CFO
- BRIEF-Stephen Brown notifies intention to resign as chief financial officer of STAAR Surgical